Cite
Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin.
MLA
Pop, Corina Silvia, et al. “Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with HCV Genotype 1b Related Cirrhosis Treated with Ledipasvir + Sofosbuvir ± Ribavirin.” Journal of Gastrointestinal & Liver Diseases, vol. 29, no. 4, Dec. 2020, pp. 690–92. EBSCOhost, https://doi.org/10.15403/jgld-3148.
APA
Pop, C. S., Preda, C. M., Manuc, M., Gheorghe, L. S., Istratescu, D., Chifulescu, A. E., Voiosu, T., Diculescu, M., Tieranu, C., & Iliescu, L. (2020). Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin. Journal of Gastrointestinal & Liver Diseases, 29(4), 690–692. https://doi.org/10.15403/jgld-3148
Chicago
Pop, Corina Silvia, Carmen Monica Preda, Mircea Manuc, Liliana Simona Gheorghe, Doina Istratescu, Andreea Elena Chifulescu, Theodor Voiosu, Mircea Diculescu, Cristian Tieranu, and Laura Iliescu. 2020. “Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with HCV Genotype 1b Related Cirrhosis Treated with Ledipasvir + Sofosbuvir ± Ribavirin.” Journal of Gastrointestinal & Liver Diseases 29 (4): 690–92. doi:10.15403/jgld-3148.